supplements that activate glp 1 GLP-1 are everywhere—but do they actually work? , As demand for weight-loss drugs grows, companies are cashing in on products claim to support GLP-1 goals, often with little Nature Made GLP-1 Companion Health

Results plateau after 6-12 months, at which point maintenance doses sustain your achievement indefinitely

GLP-1 penetration increased nearly 10% between November 2025 and June 2026 The share of Americans who say they will never use a GLP-1 fell from 66.9% in June 2025 to 62.3% in June 2026 Forecasted food volume impact has increased to between 1.4% and 3.4% across CPG categories GLP-1 users continue to trade down to smaller package sizes at significantly higher rates than other consumers, including in cereal, chips, soft drinks, coffee, and granolaPack-size reductions are increasingly appearing outside traditional discretionary categories, suggesting broader effects across grocery aisles "The industry doesn't need to decide whether GLP-1s matter anymore

Common examples include semaglutide (Ozempic), dulaglutide (Trulicity), and exenatide (Byetta), the first GLP-1 drug approved back in 2005

Effects of metformin in children and adolescents with Prader-Willi syndrome and early-onset morbid obesity: a pilot study

A New England Journal of Medicine study reported that participants taking Ozempic lost an average of 14.9% of their body weight over 68 weeks (compared to 2.4% in the placebo group)

Epidemiology and risk profile of heart failure